Psychiatrists news from FierceHealthcare
News
Psych journal discloses financial ties to industry
The editor in chief of Psychiatric Times, a leading psychiatric journal, has stepped forward to say the journal will disclose conflicts of interest that may exist within its editorial board to "help Read more...
Study: Academic medical centers have easier time with conflict-of-interest policies
Sometimes, when a healthcare institution rolls out a conflict of interest policy, it creates a hue and cry from various parties who feel that patients or staff members will be unfairly burdened in Read more...
New delusions for a modern age
There have always been psychotics--people who are out of touch with reality--and there always will be. Of late, however, psychotic visions are starting to take on themes more in tune with the times, Read more...
Psychiatric group's drugmaker ties questioned
Under attack from Congress, particularly Sen. Charles Grassley (R-IA), the psychiatric field's leading professional organization is being forced to explain its tight financial relationships with the Read more...
Harvard psychiatrists fail to reveal millions in pharma pay
A Harvard child psychiatrist with a global reputation whose work has helped to promote the use of antipsychotic meds in children apparently didn't report most of the $1.6 million in drug maker Read more...
SPOTLIGHT: HHS, DoD send mental health workers for PTSD treatment
Admitting (critics say rather belatedly) to the reality that many soldiers are suffering from post-traumatic stress disorder, the Department of Defense and HHS have announced a program under which Read more...
Bill would make pharmas, device makers disclose gifts
A measure that would force pharmaceutical companies and medical device makers to disclose gifts valued at more than $25 seems to be gathering momentum. Reps. Peter DeFazio (D-OR) and Pete Stark Read more...
ALSO NOTED: Hospitals offer more charity care; Senate approves health IT fund; and much more...
> Non-profits have begun offering charity to more patients in an effort to impress the IRS. Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




